Mucinous cystadenocarcinoma risk factors: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Common risk factors in the development of mucinous cystadenocarcinoma are [[obesity]] and post menopausal women on [[hormone replacement therapy]] and genetic predilection. | Common [[Risk factor|risk factors]] in the development of mucinous cystadenocarcinoma are [[obesity]] and [[Menopause|post menopausal]] women on [[hormone replacement therapy]] and [[Genetics|genetic]] predilection. | ||
==Risk Factors== | ==Risk Factors== | ||
* [[Obesity]] | * [[Obesity]] | ||
* Post menopausal women on [[hormone replacement therapy]]<ref>Mucinous Cystadenocarcinoma Fibroma of Ovary.Dovemed (2016). http://www.dovemed.com/diseases-conditions/mucinous-cystadenocarcinoma-fibroma-ovary/ Accessed on February 29, 2016</ref> | * [[Menopause|Post menopausal]] women on [[hormone replacement therapy]]<ref>Mucinous Cystadenocarcinoma Fibroma of Ovary.Dovemed (2016). http://www.dovemed.com/diseases-conditions/mucinous-cystadenocarcinoma-fibroma-ovary/ Accessed on February 29, 2016</ref> | ||
*Perimenopausal or post-menopausal state<ref name="pmid11075847">{{cite journal |vauthors=Lee KR, Scully RE |title=Mucinous tumors of the ovary: a clinicopathologic study of 196 borderline tumors (of intestinal type) and carcinomas, including an evaluation of 11 cases with 'pseudomyxoma peritonei' |journal=Am. J. Surg. Pathol. |volume=24 |issue=11 |pages=1447–64 |date=November 2000 |pmid=11075847 |doi= |url=}}</ref> | *[[Menopause|Perimenopausal]] or [[Menopause|post-menopausal]] state<ref name="pmid11075847">{{cite journal |vauthors=Lee KR, Scully RE |title=Mucinous tumors of the ovary: a clinicopathologic study of 196 borderline tumors (of intestinal type) and carcinomas, including an evaluation of 11 cases with 'pseudomyxoma peritonei' |journal=Am. J. Surg. Pathol. |volume=24 |issue=11 |pages=1447–64 |date=November 2000 |pmid=11075847 |doi= |url=}}</ref> | ||
*Smoking | *[[Smoking]] | ||
*KRAS mutation | *[[KRAS]] [[mutation]] | ||
==References== | ==References== | ||
Revision as of 13:22, 2 May 2019
|
Mucinous cystadenocarcinoma Microchapters |
|
Differentiating Mucinous Cystadenocarcinoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Mucinous cystadenocarcinoma risk factors On the Web |
|
American Roentgen Ray Society Images of Mucinous cystadenocarcinoma risk factors |
|
Directions to Hospitals Treating Mucinous cystadenocarcinoma |
|
Risk calculators and risk factors for Mucinous cystadenocarcinoma risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Qurrat-ul-ain Abid, M.D.[2]; Ammu Susheela, M.D. [3]
Overview
Common risk factors in the development of mucinous cystadenocarcinoma are obesity and post menopausal women on hormone replacement therapy and genetic predilection.
Risk Factors
- Obesity
- Post menopausal women on hormone replacement therapy[1]
- Perimenopausal or post-menopausal state[2]
- Smoking
- KRAS mutation
References
- ↑ Mucinous Cystadenocarcinoma Fibroma of Ovary.Dovemed (2016). http://www.dovemed.com/diseases-conditions/mucinous-cystadenocarcinoma-fibroma-ovary/ Accessed on February 29, 2016
- ↑ Lee KR, Scully RE (November 2000). "Mucinous tumors of the ovary: a clinicopathologic study of 196 borderline tumors (of intestinal type) and carcinomas, including an evaluation of 11 cases with 'pseudomyxoma peritonei'". Am. J. Surg. Pathol. 24 (11): 1447–64. PMID 11075847.